Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

F Faghihzadeh, P Adibi, R Rafiei, A Hekmatdoost - Nutrition research, 2014 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …
被引用次数：343 相关文章
[PDF] iaun.ac.ir

[PDF][PDF] Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

F Faghihzadeh, P Adibi, R Rafiei, A Hekmatdoost - 2014 - research.iaun.ac.ir
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

F Faghihzadeh, P Adibi, R Rafiei, A Hekmatdoost - Nutrition Research, 2014 - infona.pl
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …

[引用][C] Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

F FAGHIHZADEH, P ADIBI, R RAFIEI… - … research (New York …, 2014 - pascal-francis.inist.fr
Resveratrol supplementation improves inflammatory biomarkers in patients with
nonalcoholic fatty liver disease CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.

F Faghihzadeh, P Adibi, R Rafiei… - … Research (New York …, 2014 - europepmc.org
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …
[PDF] academia.edu

[PDF][PDF] Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease☆

F Faghihzadeh, P Adibi, R Rafiei, A Hekmatdoost - 2014 - academia.edu
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …
[PDF] psu.edu

[PDF][PDF] Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

F Faghihzadeh, P Adibi, R Rafiei, A Hekmatdoost - 2014 - Citeseer
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

F Faghihzadeh, P Adibi, R Rafiei, A Hekmatdoost - 2014 - pubmed.ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Resveratrol is a polyphenolic compound with antioxidant capacity that shows …

[引用][C] Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

F Faghihzadeh, P Adibi, R Rafiei, A Hekmatdoost - Nutrition Research, 2014 - cir.nii.ac.jp
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic
fatty liver disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ …

[引用][C] Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

F FAGHIHZADEH, P ADIBI, R RAFIEI… - Nutrition research, 2014 - Elsevier